Medscape Medical Minute

F. Perry Wilson, MD, MSCE

June 08, 2023

Today on the Medscape Medical Minute: Only 7% of patients with cancer are getting guideline-recommended germline genetic testing; an experimental drug shows early promise in reducing liver fat in patients with NASH; and UK researchers report that long COVID symptoms are more severe in menopausal women.

In Today's Episode

F. Perry Wilson, MD, MSCE, is an associate professor of medicine and director of the Clinical and Translational Research Accelerator at the Yale School of Medicine.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.